You Failed the ABIM Hematology or Medical Oncology Boards. Here Is What Actually Happens Next.

Written by Dr. Roupen Odabashian MD, FRCPC, FASC
Hematologist-Oncologist | Founder, MeDucation AI | Updated August 2026

The number nobody gives you on the day you find out: ABIM's own published ultimate pass rate is 98 percent for both Hematology and Medical Oncology, for the cohort of physicians whose board eligibility expired in 2025.^[1][2] Almost everyone who fails and retakes eventually certifies. You have seven years of board eligibility.^[4] ABIM publishes no limit on the number of attempts. Your medical license is not affected, and ABIM states plainly that it "does not confirm or report the Board Eligibility status of its candidates."^[4] What should occupy you today is the calendar, because these exams run once a year and registration closes in June for a November exam.^[9]

What are the seven facts that should change what you do this week?

What does the 98 percent ultimate pass rate actually mean?

That when ABIM followed a full cohort to the end of its board eligibility, 98 percent were certified. Verbatim from the 2026 Hematology Diplomate Report: "The ultimate Hematology Certification Examination pass rate was 98% for the cohort of physicians whose board eligibility to sit for the exam expired in 2025."^[1] The 2026 Medical Oncology Diplomate Report carries the identical sentence for Medical Oncology.^[2] Both add: "Most physicians retake the exam if they failed the first attempt."^[1][2]

How common is failing?

Source: ABIM First-Time Taker Pass Rates.^[3] In 2025 that is roughly 44 hematologists and 75 oncologists. You are one of a cohort large enough to fill a lecture hall. ABIM's caution: "Changes in certification exam pass rates should be interpreted with caution; pass rates are subject to change over time due to adjustments in performance standards, updates to the examination blueprints, and advances in medical knowledge and practice."^[1][2]

When is the next exam, and have I already missed it?

The full calendar as published by ABIM as of August 2026.^[9]

All deadlines are 11:59 p.m. ET. ABIM states: "In fairness to all candidates, ABIM adheres firmly to its published deadlines."^[9] ABIM also states that all dates are subject to change, so confirm on the Hematology exam page and the Medical Oncology exam page before relying on any of it.

Why does the timing trap catch so many people?

Because results release "within three months of the last date of the exam."^[9] You sit in November, learn you failed around February, and then have roughly four months to decide, register and pay before the June 15 deadline for the following November. Most people spend those four months not thinking about it, and that is how a one-year delay becomes a two-year delay.

Concretely, as of August 2026 the 2026 registration window has closed: June 15, 2026 for standard registration and June 28, 2026 for late. If you failed the November 2025 exam and did not register in that window, you cannot sit in November 2026. Your next sitting is November 2027, and registration for it opens December 1, 2026. Put that date in your calendar tonight, not in March.

Exam day is about 10 hours: four sessions of up to 60 multiple-choice questions each, a maximum of 240, with 100 total minutes of break split across three breaks.^[9]

How do I read my score report so that it changes what I do?

Your score report is the most valuable study tool you will get this year, and most people read the pass/fail line and never open it again.

What does the overall number mean?

"Overall performance is reported on a standardized score scale ranging from 200 to 800, with a mean of 500, for traditional assessments."^[6] The reference group is "first-time examinees who completed a similar assessment during the current or a previous administration."^[6] The decision rests on the entire exam, and unanswered questions are scored as incorrect.^[9]

ABIM does not publish the current passing score for Hematology or Medical Oncology. If you have seen 366 quoted online as the passing score, ignore it: that number comes from ABIM's illustrative sample report, a Spring 2015 Internal Medicine maintenance of certification example, not a heme or med onc exam.^[7] The accurate statement is that the standard is an absolute, criterion-referenced score on the 200 to 800 scale, set per exam, and not published.

How far would my score move if I just took it again?

About 12 points, and that is ABIM's arithmetic, not mine: "an average examinee would have a score of 500 and a standard error of 12 (i.e. 500 ±12) … if this examinee were to retake the exam without any additional preparation, the expected score for their retake would fall between 488 and 512. The standard error of measurement does not affect pass/fail decisions."^[6]

If you were 30 points below the line, retaking with the same preparation puts you, on average, back where you were. The measurement noise is small. The gap is real. That should decide whether you build a study plan or simply re-register.

Was I graded on a curve against a strong cohort?

No, and the belief is worth killing because it makes people blame the year instead of the gap. ABIM uses the Angoff method, which is criterion-referenced: content experts review each question and estimate "What is the probability that this type of physician [one just barely qualified to merit certification] will correctly answer this question?" The standard is then set by the designated ABIM Specialty Board or Advisory Committee.^[6] ABIM states that "no predetermined percentage of examinees will pass or fail," and that the minimum passing score "reflects an absolute standard that is independent of the performance of any group of candidates."^[6][9] You were measured against a fixed bar. Emotionally that is worse; practically it is better, because a fixed bar can be studied toward.

What do the content-area subscores tell me, and what do they not?

Relative strengths and weaknesses, and not much more. ABIM: "Content area scores provide feedback on your relative strengths and weaknesses… They are reported in standard deviation units and are on a different scale than your overall score… you should be cautious in interpreting the content area scores."^[6] They use the Empirical Bayes method, not percent correct, so do not read one as "I got 62 percent of coagulation right." Each rests on fewer items than the overall score, which is why ABIM warns you off overreading them.

The part almost nobody uses is further down: the report includes "a detailed listing of exam content, showing the blueprint content description and cognitive task, that you missed in each area."^[7] A per-topic table of what you got wrong, mapped to the blueprint, with the cognitive task attached. It tells you not only that you missed hepatocellular carcinoma items but whether you missed them on diagnosis or on treatment decisions, and that changes what you study. Transcribe it into a spreadsheet. It is the only individualized data anyone will give you about this exam.

Does failing affect my license, my privileges or my job?

Your license, no. ABIM says so itself: "ABIM receives no public funds and has no licensing authority or function… ABIM does not confer privileges to practice, nor does ABIM intend either to interfere with or to restrict the professional activities of a licensed physician based on certification status."^[5]

The relationship runs the other way. To be admitted to an ABIM certification exam you must hold "a permanent, valid, unrestricted and unchallenged medical license"; a restricted, suspended, revoked or surrendered license makes you ineligible.^[4] Licensure gates certification, not the reverse.

Credentialing and employment are separate, and here I want to be careful about what I do not know. Hospitals may lawfully use board certification as one of their threshold criteria for medical staff privileges, and employment contracts commonly require certification within a defined period.^[12] What I could not verify from a primary source, and so will not assert: current Joint Commission language on certification in credentialing, any current statistic on what share of US hospitals require certification in medical staff bylaws, and any current insurance or payer panel requirement. Those are exactly the claims that circulate on forums with no source attached. Read your own contract and your hospital's bylaws and ask your chair what your institution's window is. Those documents answer your question better than the internet, this article included.

Who finds out that I failed?

Fewer people than you fear, and the difference between "not certified" and "failed" matters a great deal.

The policy language, verbatim: "ABIM provides residency and fellowship training program directors with information about a trainee's prior training and pass/fail status on certification examinations. If a trainee has given permission, ABIM will provide the program director with the trainee's score on their first attempt at the certification examination for that area of training."^[4] Your PD knows. Your PD does not know your number unless you allowed it, and never for a second attempt.

On the public record: "ABIM considers the certification or recertification status of its candidates and diplomates to be public information," provided to the Federation of State Medical Boards, to ABMS and to other credential and licensure verification organizations.^[4] Read that precisely. What becomes public is that you are not certified. A directory that does not list you as certified is not a public record that you failed an exam.

And the line I would want if I were you: "ABIM does not confirm or report the Board Eligibility status of its candidates. Parties interested in a candidate's Board Eligibility status may wish to communicate directly with the candidate and/or with the appropriate training program."^[4] ABIM points inquirers back at you. On your own written request, ABIM may confirm that an application is in process and the year you were last admitted to an examination.^[4]

How many times can I retake it, and what happens after seven years?

ABIM does not publish a limit on the number of attempts. I phrase it that way rather than "unlimited," because a verified absence of a published cap is not a published guarantee. The real constraints are structural: one administration per year, inside a seven-year window. The calendar sets the ceiling, not a rule.

The window, verbatim: "As of July 2012, the American Board of Internal Medicine considers all internal medicine and subspecialist physicians who have met the standards for board certification … to be 'Board Eligible' in the relevant specialty for a period of seven years. The seven-year period of Board Eligibility shall begin upon the candidate's successful completion of the initial certification requirements in their field or July 1, 2012, whichever is later. During the period of Board Eligibility, the candidate may apply for the certification examination in the relevant specialty. If the candidate does not become board certified during the seven-year period of Board Eligibility, the candidate will no longer be deemed 'Board Eligible' and may no longer represent himself or herself as 'Board Eligible.'"^[4]

That last clause has teeth. After year seven, "board eligible" comes off your CV, your practice website and your credentialing forms, and misrepresenting the status may lead to disciplinary sanctions.^[4]

What is the retraining pathway if my eligibility expires?

It exists, and it costs a year of your life. Verbatim: "A candidate who is no longer Board Eligible may nevertheless apply for a certification examination, but only if the candidate has: (i) completed a year of retraining in the relevant specialty after the expiry of the candidate's period of Board Eligibility, but no more than seven years before the application; and (ii) met all other requirements for board certification in effect at that time."^[4]

• Retraining means one additional year in an ACGME, RCPSC or Collège des Médecins du Québec accredited residency or fellowship.^[4]

• "Attending-level or hospitalist employee duties, practice monitoring or CME courses will not meet the requirements for retraining."^[4] A year of attending work in a heme/onc practice does not count. Neither does a review course.

• Your program director must submit a retraining proposal to ABIM for approval before retraining begins.^[4] Starting first and asking later is how people lose a year.

One more clause: "Candidates agree that if ABIM determines that, in its judgment, the results of their examination are unreliable, ABIM may require the candidates to retake an examination at its next administration."^[4]

What is this going to cost me?

Fees as published at August 2026.^[8][9] ABIM reserves the right to change fees, exams, policies and procedures at any time without advance notice. Active military and documented medical emergencies may be eligible for additional refunds through ABIM. On the rescore, ABIM itself states that "a rescore is unlikely to change the outcome."^[9] If you were two points away and cannot let it go, spend the $250 for your own peace. As a strategy, it is worse value than a question bank.

What is actually on the exam?

Both blueprints were updated January 2026. Take them from ABIM and nowhere else: one major vendor page still lists the hematology blueprint's fifth category under an outdated name, where current ABIM language reads Cellular Therapy. The canonical index is the ABIM exam blueprints page.

Hematology certification blueprint, January 2026

Hematology Certification Examination Blueprint (PDF).

The blueprint adds that questions in these categories "may also address topics related to pregnancy and contraception that are important to the practice of hematology (approximately 4% of the exam)." Format is up to 240 single-best-answer multiple-choice questions, "of which approximately 40 are new questions that do not count in the examinee's score."

A caution on the expanded blueprint. ABIM publishes sub-category weights inside the hematology PDF: disorders of red blood cells or iron near 21 percent, B-cell neoplasms near 13 percent, thrombosis near 10 percent, acute leukemias and myelodysplasia near 8 percent. Treat those as indicative, not exhaustive, because that PDF uses an older layout in which the percentages sit in a separate visual column and extract imperfectly. The five top-level percentages are solid. Build on those.

Medical Oncology certification blueprint, January 2026

Medical Oncology Certification Examination Blueprint (PDF).

One quirk, because it will confuse you if you read the whole PDF: the page 1 summary table names the 11 percent category "Palliative Care, Survivorship, and Communication," while the page 2 content outline heads the same section "Palliative Care, Survivorship, and Oncologic Complications." Both are 11 percent; only the label differs. Study it as palliative care, survivorship, communication and oncologic complications and you have covered both.

Why the medical oncology task distribution should reshape your studying

Sixty percent of that exam is management; 5 percent is basic science. If your instinct after failing is to reread mechanism chapters, it is aimed at 5 percent of the exam. The high-yield behavior is answering "what do you do next for this patient" repeatedly: first-line versus second-line selection, biomarker-directed therapy, when to stop, when to involve palliative care. That is why NCCN algorithms and landmark trial results earn more per hour than pathway diagrams. If you are rebuilding from scratch, our six-month study plan for the ABIM hematology and oncology board exams maps blueprint weights onto weekly blocks.

What does the evidence say predicts passing?

Start with the gap, because it is large. There is no published study on what predicts passing an ABIM subspecialty exam on the second attempt, and no published evaluation of a remediation program for physicians who failed ABIM hematology or medical oncology. The literature predicts first-attempt failure; it does not describe recovery from it. Anyone selling a "proven remediation protocol" for this exam is selling something unstudied. What follows is inference from first-attempt prediction research, labelled as inference deliberately.

The most relevant study is heme/onc specific. Collichio and colleagues, in the Journal of Cancer Education in 2017 with co-authors from ABIM, NBME, ASH and ASCO, compared in-training examination scores against program director assessments.^[10] Hematology in-training exam scores were the strongest predictor of Hematology Certification Examination scores (β = 0.41; odds ratio for passing 1.012, 95% CI 1.008 to 1.015). Oncology in-training exam scores were the strongest predictor of Medical Oncology Certification Examination scores (β = 0.45; odds ratio 1.013, 95% CI 1.011 to 1.016). Program director rating of medical knowledge was the weakest predictor (β = 0.07) and was not significantly predictive of hematology certification scores.

The translation: objective self-testing tracks your board outcome, and supervisor impressions do not. If your attendings told you that you were doing fine and you failed, that is not a contradiction, it is what this study predicts. Stop asking people how you are doing and start measuring it.

Internal medicine evidence points the same way. Across 9,676 PGY-1, 11,424 PGY-2 and 10,239 PGY-3 internal medicine residents, all examined variables predicted passing, "with IM-ITE scores having the strongest association and USMLE Step scores being the next strongest predictors."^[11] The same work found residents "must score higher on the IM-ITE with each subsequent administration to maintain the same estimated probability of passing," a caution against treating one good practice score as a finish line. A smaller cohort found 14 of 166 internal medicine graduates (8.4%) failed on first attempt, associated with lower in-training percentile at every year (Seaberg et al, Medical Education Online, 2023), and a validated nomogram built on in-training scores predicted passing with a concordance index of 0.98 internally and 0.94 externally (Brateanu et al, Medical Education Online, 2012). Internal medicine cohorts, not heme/onc, and correlational.

The inference: build the retake year around repeated, timed, scored self-testing under exam-like conditions and around your report's list of missed blueprint topics. Not around rereading.

Which review resources have published prices?

Only prices the vendor actually publishes are listed. Where a price sits behind a login, I say so instead of guessing.

Prices as published at August 2026, from the ASH store, the ASH Hematology Review Series listing, the ASCO-SEP product page and BoardVitals. ASCO notes that the ASCO-SEP digital edition and question bank do not offer CME credits or MOC points, and that the digital edition has no chapter assessments because all questions live in the question bank. BoardVitals' on-page blueprint summary is out of date, so use them for questions and take the blueprint from ABIM.

Two corrections to almost every heme/onc board prep list online

• TrueLearn has no hematology or medical oncology product. Their full catalog lists no heme or onc SmartBank; internal medicine appears only as IM Prep. Any list recommending TrueLearn for these exams has not been checked against TrueLearn's own catalog.

• MedStudy's catalog is internal medicine and pediatrics. Their question bank advertises 1,700+ internal medicine questions, and the resident review course listed at $899 is the internal medicine course. No heme/onc-specific product exists there.

I also could not verify that the Osler Institute offers an ABIM medical oncology or hematology review course at all. Results attaching prices like $800 or $1,375 to "Osler oncology" point at other specialties, notably radiation oncology, so I am not listing it.

On my own product: MeDucation AI's question bank is written and reviewed by practicing, board-certified hematologist-oncologists, not AI-generated, with an AI study layer around it. It is the wrong choice if you need a structured lecture course rather than practice questions, where the ASH Hematology Review Series at $110 for trainees beats anything I sell, or if you want CME and MOC credit alongside studying, which BoardVitals' add-on provides and mine does not. For a side-by-side including mine, see our comparison of heme/onc question banks and our honest review of whether ASH-SAP is worth it.

Frequently asked questions

How many times can I retake the ABIM hematology or medical oncology exam?

ABIM does not publish a limit on the number of attempts. The practical constraints are that the exam is administered once per year and that board eligibility lasts seven years from completion of your initial certification requirements, so the calendar sets the ceiling rather than a stated rule.

Does failing the ABIM boards affect my medical license?

No. ABIM states that it has no licensing authority or function, does not confer privileges to practice, and does not intend to interfere with or restrict the professional activities of a licensed physician based on certification status. The relationship runs the other way: you must hold a permanent, valid, unrestricted and unchallenged medical license to be admitted to an ABIM certification exam.

Will my program director be told that I failed?

Yes. ABIM provides program directors with pass/fail status on certification examinations automatically. Your numeric score is provided to your program director only if you have given permission, and only for your first attempt at that exam.

Is a $250 rescore worth requesting?

Usually not as a strategy. ABIM states that a rescore is unlikely to change the outcome. A rescore costs $250, must be requested in writing within six months of results release, and results are mailed within eight weeks.

What is the passing score for the ABIM hematology and medical oncology exams?

ABIM does not publish it. Scores are reported on a standardized 200 to 800 scale with a mean of 500, and the passing standard is an absolute, criterion-referenced score set for each exam using the Angoff method. The figure of 366 that circulates online comes from a Spring 2015 Internal Medicine maintenance of certification sample report and is not the hematology or medical oncology passing score.

What should I actually do, in what order?

This week

1. Open your score report, find the listing of blueprint content and cognitive task missed in each area, and transcribe it into a spreadsheet with the task in its own column.

2. Calendar the two dates that govern your next two years: registration opens December 1 and closes June 15, with late registration to June 28 and a $400 non-refundable fee.

3. Have the conversation with your program director or chair before they raise it. They have the pass/fail result already. They do not have your score unless you give it.

4. Read your employment contract and your hospital's medical staff bylaws for the certification clause. Get the actual language, not a rumor about it.

This month

5. Map that spreadsheet onto the January 2026 blueprint from ABIM, not from a vendor page, and weight your plan by the published percentages.

6. In medical oncology, restructure toward management questions: treatment and care decisions are 60 percent of the exam, basic science is 5 percent.

7. Pick one question bank and one review source and commit. Cross-shopping four products is a way of not studying.

8. Schedule scored, timed self-testing at fixed intervals. That is the behavior the published evidence associates with certification outcome. Feeling ready is not.

This year

9. Register the day the window opens, not the week it closes.

10. Count your remaining board eligibility. If you are near year seven, get advice now: retraining requires a full accredited year and a program director proposal approved by ABIM before it begins.

11. Simulate the day at least once. Roughly 10 hours, four sessions of up to 60 questions, 100 total minutes of break. Stamina is a testable variable.

12. Skip the rescore unless you need it for your own peace of mind.

One human sentence and then I will leave you alone. I have watched excellent clinicians fail this exam and then certify, and nothing about their careers ended in between. The 98 percent is not a consolation prize, it is what happens to people in your position. The work in front of you is a spreadsheet and a calendar entry, and you can do both tonight.

References

1. American Board of Internal Medicine. 2026 Hematology Diplomate Report (PDF).

2. American Board of Internal Medicine. 2026 Medical Oncology Diplomate Report (PDF).

3. American Board of Internal Medicine. First-Time Taker Pass Rates, Initial Certification, 2008 to 2025 (PDF).

4. American Board of Internal Medicine. General Policies: board eligibility, retraining, licensure, confidentiality and reporting.

5. American Board of Internal Medicine. Policies and Procedures for Certification, December 2025 (PDF).

6. American Board of Internal Medicine. How Exams Are Scored.

7. American Board of Internal Medicine. Sample Score Report (PDF). Illustrative Internal Medicine maintenance of certification example, Spring 2015.

8. American Board of Internal Medicine. Exam Fees and Refund Policies.

9. American Board of Internal Medicine. Hematology: Register, Prepare for and Take Your Exam.American Board of Internal Medicine. Medical Oncology: Register, Prepare for and Take Your Exam.

10. Collichio FA, Hess BJ, Muchmore EA, Duhigg L, Lipner RS, Haist S, Hawley JL, Morrison CA, Clayton CP, Raymond MJ, Kayoumi KM, Gitlin SD. Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance. J Cancer Educ. 2017;32(3):647-654. doi:10.1007/s13187-016-0993-6

11. McDonald FS, Jurich D, Duhigg LM, et al. Acad Med. 2020;95(9):1388-1395. doi:10.1097/ACM.0000000000003382

12. Lowy J. Board Certification as Prerequisite for Hospital Staff Privileges. AMA Journal of Ethics (Virtual Mentor). 2005;7(4):284-287. Full text. Cited only for the conceptual distinction between licensure and hospital credentialing. This is a 2005 secondary source and not current Joint Commission policy.